Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2010 Jan;54(1):543-5.
doi: 10.1128/AAC.00733-09. Epub 2009 Oct 12.

Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model

Affiliations
Comparative Study

Relative contributions of active mediated transport and passive diffusion of fluoroquinolones with various lipophilicities in a Calu-3 lung epithelial cell model

Julien Brillault et al. Antimicrob Agents Chemother. 2010 Jan.

Abstract

The transport characteristics of six fluoroquinolones (FQs) with various lipophilicities were compared in a Calu-3 cell model. For each FQ, an active polarized transport was observed in the direction of the apical side. However, the apparent permeability of FQs resulted from active transport and passive diffusion that were highly variable between compounds and mainly governed by lipophilicity. Therefore, active transport was predominant for compounds with relatively low lipophilicity but minor for FQs with higher lipophilicity.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Linear relationship between the apparent permeability of FQs in the presence of PSC-833 and the log D. The linear regression fitted the data with the following equation: Papp = 6.1 log D + 7.5. Data are expressed as mean ± SEM (n = 6).

References

    1. Alvarez, A. I., M. Perez, J. G. Prieto, A. J. Molina, R. Real, and G. Merino. 2008. Fluoroquinolone efflux mediated by ABC transporters. J. Pharm. Sci. 97:3483-3493. - PubMed
    1. Brillault, J., W. V. De Castro, T. Harnois, A. Kitzis, J. C. Olivier, and W. Couet. 2009. P-glycoprotein-mediated transport of moxifloxacin in a Calu-3 lung epithelial cell model. Antimicrob. Agents Chemother. 53:1457-1462. - PMC - PubMed
    1. Endter, S., U. Becker, N. Daum, H. Huwer, C. M. Lehr, M. Gumbleton, and C. Ehrhardt. 2007. P-glycoprotein (MDR1) functional activity in human alveolar epithelial cell monolayers. Cell Tissue Res. 328:77-84. - PubMed
    1. Hamilton, K. O., E. Topp, I. Makagiansar, T. Siahaan, M. Yazdanian, and K. L. Audus. 2001. Multidrug resistance-associated protein-1 functional activity in Calu-3 cells. J. Pharmacol. Exp. Ther. 298:1199-1205. - PubMed
    1. Langlois, M.-H., M. Montagut, J.-P. Dubost, J. Grellet, and M.-C. Saux. 2005. Protonation equilibrium and lipophilicity of moxifloxacin. J. Pharm. Biomed. Anal. 37:389-393. - PubMed

Publication types

MeSH terms